Journal of Dental Research

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Van Dyke, T. E.
Right arrow Articles by Serhan, C.N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Dental Research, Vol. 82, No. 2, 82-90 (2003)
DOI: 10.1177/154405910308200202

Resolution of Inflammation: A New Paradigm for the Pathogenesis of Periodontal Diseases

T. E. Van Dyke1,* and C.N. Serhan2

1 Department of Periodontology and Oral Biology, Boston University, Goldman School of Dental Medicine, 100 East Newton Street, Boston, MA 02118; and
2 Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115;


Figure 1
View larger version (26K):
[in this window]
[in a new window]

 
Figure 1. Lipid mediators derived from arachidonic acid in inflammation. Prostaglandins and leukotrienes generated by cyclooxygenase (COX) and the 5, 12, and 15 lipoxygenases amplify inflammation. Lipoxins are generated through transcellular biosynthetic routes through the action of two lipoxygenases on the same arachidonic acid molecule to act as endogenous stop signals in inflammation. NSAID: Non-steroidal anti-inflammatory drug.

 

Figure 2A
View larger version (28K):
[in this window]
[in a new window]

 
Figure 2A. Local and regional lipoxin biosynthesis by vascular and mucosal routes.

 

Figure 2B
View larger version (20K):
[in this window]
[in a new window]

 
Figure 2B. Lipoxin biosynthetic regulators.

 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?